Masayuki Hiraki, Junichi Nishimura, Hidekazu Takahashi, Xin Wu, Yusuke Takahashi, Masaaki Miyo, . . . Hirofumi Yamamoto. (2015). Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer. Elsevier.
Chicago Style (17th ed.) CitationMasayuki Hiraki, et al. Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer. Elsevier, 2015.
MLA (9th ed.) CitationMasayuki Hiraki, et al. Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer. Elsevier, 2015.
Warning: These citations may not always be 100% accurate.